CD248 and sarcoma: Recent studies by this group on endosialin-positive sarcoma cell lines have shown maintenance of endosialin expression in sarcoma side population cells with stem-cell like properties, reinforcing the hypothesis that endosialin is a potential therapeutic target in sarcoma (Rouleau et al, 2012; Sun et al, 2015).